tiprankstipranks
Advertisement
Advertisement

VSTM Stock Latest News

Verastem price target lowered to $18 from $19 at BTIG
The FlyVerastem price target lowered to $18 from $19 at BTIG
8h ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
PremiumThe Fly
Verastem price target raised to $18 from $16 at Alliance Global
9h ago
VSTM
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
PremiumThe Fly
Verastem reports Q1 adjusted EPS (43c), consensus (47c)
23h ago
VSTM
Verastem Updates Strategy for RAS/MAPK Oncology Pipeline
PremiumCompany Announcements
Verastem Updates Strategy for RAS/MAPK Oncology Pipeline
24h ago
8K
VSTM
VSTM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
VSTM Upcoming Earnings Report: What to Expect?
3d ago
VSTM
Verastem announces launch of Reimagine Recurrent LGSOC campaign
PremiumThe FlyVerastem announces launch of Reimagine Recurrent LGSOC campaign
8d ago
VSTM
Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook
Premium
Ratings
Buy Rating on Verastem: Favorable Risk‑Reward for VS‑7375 Driven by Superior Early Efficacy vs. Zoldonrasib and Improving Safety Outlook
17d ago
VSTM
3 Best Stocks to Buy Today, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, According to Top Analysts
26d ago
BBOT
VSTM
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
PremiumRatings
Reaffirming Buy on Durable AVMAPKI FAKZYNJA Benefit in Recurrent LGSOC, Supported by Robust 2-Year RAMP 201 Data
28d ago
VSTM
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
PremiumThe Fly
Verastem announces two-year median follow-up data on AVMAPKI FAKZYNJA combo
28d ago
VSTM
Verastem assumed with a Buy at Jefferies
PremiumThe Fly
Verastem assumed with a Buy at Jefferies
1M ago
VSTM
Verastem management to meet with Cantor
PremiumThe Fly
Verastem management to meet with Cantor
1M ago
VSTM
Verastem assumed with a Buy at BTIG
PremiumThe FlyVerastem assumed with a Buy at BTIG
2M ago
VSTM
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
Premium
Ratings
Undervalued Growth Story in Verastem: Strong AVMAPKI FAKZYNJA Launch and Promising KRASG12D Pipeline Drive Buy Rating and $19 Target
2M ago
VSTM
Verastem Earnings Call: Early Momentum, Long Runway Risks
Premium
Company Announcements
Verastem Earnings Call: Early Momentum, Long Runway Risks
2M ago
VSTM
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
PremiumRatings
Verastem: Differentiated Next‑Generation KRAS G12D Inhibitor VS‑7375 Underpins Buy Rating on Compelling Early Clinical Data
2M ago
VSTM
Verastem price target raised to $18 from $16 at Alliance Global
PremiumThe Fly
Verastem price target raised to $18 from $16 at Alliance Global
2M ago
VSTM
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
PremiumRatings
Verastem: Strong Commercial Uptake and Expanding RAS/MAPK Oncology Pipeline Underpin Buy Rating and $18 Target
2M ago
VSTM
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
PremiumCompany Announcements
Verastem Highlights AVMAPKI FAKZYNJA Strategy and Pipeline Risks
2M ago
8K
VSTM
Verastem reports Q4 adjusted EPS (48c), consensus (50c)
PremiumThe FlyVerastem reports Q4 adjusted EPS (48c), consensus (50c)
2M ago
VSTM
Verastem announces upcoming key milestones
Premium
The Fly
Verastem announces upcoming key milestones
2M ago
VSTM
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
Premium
Market News
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026
2M ago
UPB
VERA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >